(Q35142223)

6 August 2017

1 reference

title

Helicobacter pylori infection in patients with liver cirrhosis: facts and fictions (English)

1 reference

Helicobacter pylori infectious disease

6 August 2017

0 references

0 references

1 reference

Zullo A

1

1 reference

6 August 2017

Hassan C

series ordinal

2

1 reference

6 August 2017

Morini S

series ordinal

3

1 reference

6 August 2017

publication date

1 March 2003

1 reference

Digestive and Liver Disease

6 August 2017

published in

1 reference

6 August 2017

volume

35

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

197-205

1 reference

Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Mortality from liver cirrhosis in Italy: Proportion associated with consumption of alcohol

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

The rise and fall in primary liver cancer mortality in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

The stomach in liver cirrhosis. Endoscopic, morphological, and clinical correlations

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Treatment of hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Helicobacter pylori: diseases, tests and treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Helicobacter pylori and liver: an actor with three roles?

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Role of Helicobacter pylori in cirrhotic patients with peptic ulcer. A serological study

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Helicobacter pylori in cirrhotic patients with peptic ulcer disease: a prospective, case controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Helicobacter pylori infection and peptic ulcer disease in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Seroprevalence and epidemiology of Helicobacter pylori infection in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

High prevalence of Helicobacter pylori in liver cirrhosis: relationship with clinical and endoscopic features and the risk of peptic ulcer

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Atrophic corpus gastritis and Helicobacter pylori infection in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Helicobacter pylori seroprevalence in cirrhotic patients with hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Helicobacter infection and cirrhosis in hepatitis C virus carriage: is it an innocent bystander or a troublemaker?

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Helicobacter pylori seroprevalence in hepatitis C virus positive patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Gastric secretion in Chinese patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Congestive gastropathy and Helicobacter pylori: an endoscopic and morphometric study

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Natural history of congestive gastropathy in cirrhosis. The Liver Study Group of V. Cervello Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Helicobacter pylori infection among patients with alcoholic and nonalcoholic cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Helicobacter pylori infection in congestive gastropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Evaluation of 24-hour gastric acidity in patients with hepatic cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Helicobacter pylori, hyperammonemia and subclinical portosystemic encephalopathy: effects of eradication.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Analysis of risk factors for chronic hepatic encephalopathy: the role of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Role of Helicobacter pylori in cirrhotic patients with dyspepsia: a 13C-urea breath test study

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Duodenal erosions, a common and distinctive feature of portal hypertensive duodenopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Role of Helicobacter pylori infection and its eradication in patients with subclinical hepatic encephalopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Helicobacter pylori infection is not associated with subclinical hepatic encephalopathy in stable cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Impairment of cytochrome P-450-dependent liver activity in cirrhotic patients with Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Low incidence of Helicobacter pylori infection in patients with duodenal ulcer and chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Endogenous prostaglandin E2 in gastric mucosa of patients with alcoholic cirrhosis and portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Reduced gastric mucosal blood flow in patients with portal-hypertensive gastropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Impaired oxygenation of gastric mucosa in portal hypertension. The basis for increased susceptibility to injury

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Gastric secretion and peptic ulceration in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Helicobacter pylori is a risk factor for peptic ulcer disease in cirrhotic patients. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Evaluation of Helicobacter pylori diagnostic methods in patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Effects of ammonia solution on the gastric mucosa in cirrhotic rats and therapeutic effects of geranylgeranylacetone

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Relation between gastric cancer and previous peptic ulcer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

The risk of stomach cancer in patients with gastric or duodenal ulcer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Associations of peptic ulcer and gastric cancer with other diseases in US veterans

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Gastric cancer prevalence in patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Gastric epithelial cell proliferation in patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Zinc, ammonia, and Helicobacter pylori infection in liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Esophageal carcinogenesis in the rat: zinc deficiency and alcohol effects on tumor induction.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Colonization by Helicobacter pylori and its relationship to histological changes in the gastric mucosa in portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Severe portal hypertensive gastropathy and antral vascular ectasia are distinct entities in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Watermelon stomach: not only an antral disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Gastric cardia inflammation: role of Helicobacter pylori infection and symptoms of gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Helicobacter pylori lipopolysaccharide provokes iNOS-mediated acute systemic microvascular inflammatory responses in rat cardiac, hepatic, renal and pulmonary tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Effects of chronic administration of Helicobacter pylori extracts on rat gastric mucosal microcirculation in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Gastric emptying and Helicobacter pylori infection in duodenal ulcer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Gastric permeability to sucrose is increased in portal hypertensive gastropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

1 reference

7 January 2021

Maximal Rates of Excretion and Synthesis of Urea in Normal and Cirrhotic Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Helicobacter pylori, ammonia and the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Hyperammonaemia and Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Hyperammonaemia and Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Helicobacter pylori infection induces hyperammonaemia in Mongolian gerbils with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Helicobacter pylori, harmful to the brain?

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Hyperammonaemia in cirrhosis and Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Interorgan ammonia metabolism in health and disease: a surgeon's view

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Helicobacter pylori is not a risk factor for hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Helicobacter pylori, Gastric Juice, and Arterial Ammonia Levels in Patients with Cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Helicobacter pylori infection, plasma ammonia levels, and psychometric testing in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Effects of Helicobacter pylori eradication therapy on hyperammonaemia in patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

The effect of Helicobacter pylori eradication on gastric juice and blood ammonia concentrations and on visual evoked potentials in cirrhotics

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Effect of Helicobacter pylori infection on intragastric urea and ammonium concentrations in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Prescribing for patients with liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Disposition and metabolism of metronidazole in patients with liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Pharmacokinetics of clarithromycin in Helicobacter pylori eradication therapy in patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

Pharmacokinetics of [14C]omeprazole in patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900029-X

7 January 2021

10.1016/S1590-8658(03)00029-X

Identifiers

DOI

1 reference

6 August 2017

1 reference